AU4391093A - Compositions and methods for the prevention and treatment of thrombosis - Google Patents

Compositions and methods for the prevention and treatment of thrombosis

Info

Publication number
AU4391093A
AU4391093A AU43910/93A AU4391093A AU4391093A AU 4391093 A AU4391093 A AU 4391093A AU 43910/93 A AU43910/93 A AU 43910/93A AU 4391093 A AU4391093 A AU 4391093A AU 4391093 A AU4391093 A AU 4391093A
Authority
AU
Australia
Prior art keywords
thrombosis
prevention
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43910/93A
Inventor
Thorir D. Bjornsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Publication of AU4391093A publication Critical patent/AU4391093A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU43910/93A 1992-05-21 1993-05-21 Compositions and methods for the prevention and treatment of thrombosis Abandoned AU4391093A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88718692A 1992-05-21 1992-05-21
US887186 1992-05-21

Publications (1)

Publication Number Publication Date
AU4391093A true AU4391093A (en) 1993-12-13

Family

ID=25390626

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43910/93A Abandoned AU4391093A (en) 1992-05-21 1993-05-21 Compositions and methods for the prevention and treatment of thrombosis

Country Status (2)

Country Link
AU (1) AU4391093A (en)
WO (1) WO1993023064A1 (en)

Also Published As

Publication number Publication date
WO1993023064A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
AU4032989A (en) Method and compositions for the treatment and prevention of septic shock
AU3691793A (en) Gas well treatment compositions and methods
EP0717592A4 (en) Method and composition for the treatment of apathy-amotivation syndrome
AU4028995A (en) Antitumor compositions and methods of treatment
AU2103295A (en) Methods for the treatment of thrombosis
EP0695224A4 (en) Compositions and methods for waste treatment
AU4214193A (en) Bioadhesive treatment compositions and method of use
AU8044491A (en) Antitumor compositions and methods of treatment
AU6946594A (en) Methods for the treatment and prevention of diarrhea
AU3406893A (en) Method and composition for the treatment of osteoporosis
AU7370594A (en) Methods of treating apoptosis and associated conditions
AU4520893A (en) Sterilization process and composition
AU8192691A (en) Method of treatment and compositions therefore
AU2843397A (en) Agent for prophylaxis and treatment of disturbance of visual function
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
EP0688225A4 (en) Methods and compositions for the inhibition of complement activation
AU7770991A (en) Method and composition for the treatment of cancer
AU4104093A (en) Method and compositions for treatment of pyonecrotic processes
AU1097892A (en) Process and installation for the treatment of steel-mill slag
AU6979594A (en) Compositions and methods for treatment and prevention of retinal dysfunctions
IL128095A0 (en) Formulation for the treatment and/or prophylaxis of dementia
GB9317943D0 (en) Treatment of laminitis
AU4391093A (en) Compositions and methods for the prevention and treatment of thrombosis
GB9321679D0 (en) Treatment of substrates
HUT67916A (en) Hydrogenolytic reduction of peroxydic osonolysis products